Invention Grant
- Patent Title: Targeting aneurysm disease by modulating phagocytosis pathways
-
Application No.: US15510591Application Date: 2015-09-09
-
Publication No.: US10822411B2Publication Date: 2020-11-03
- Inventor: Nicholas J. Leeper , Irving L. Weissman
- Applicant: The Board of Trustees of the Leland Stanford Junior University
- Applicant Address: US CA Stanford
- Assignee: The Board of Trustees of the Leland Stanford Junior University
- Current Assignee: The Board of Trustees of the Leland Stanford Junior University
- Current Assignee Address: US CA Stanford
- Agency: Bozicevic, Field & Francis LLP
- Agent Pamela J. Sherwood
- International Application: PCT/US2015/049150 WO 20150909
- International Announcement: WO2016/044021 WO 20160324
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61K39/00 ; C07K16/28 ; A61P9/10 ; C12Q1/6883
Abstract:
In the methods of the invention, an agent that increases phagocytosis and/or efferocytosis of cellular components of coronary plaque is administered to the subject in a dose and for a period of time effective to stabilize, prevent or reduce aneurysm disease in the individual.
Public/Granted literature
- US20170291945A1 TARGETING ANEURYSM DISEASE BY MODULATING PHAGOCYTOSIS PATHWAYS Public/Granted day:2017-10-12
Information query
IPC分类:
